Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
221.80
-59.00 (-21.01%)
At close: Apr 28, 2026
Market Cap 22.10B
Revenue (ttm) 648.05M
Net Income (ttm) 197.00M
Shares Out 78.71M
EPS (ttm) 2.83
PE Ratio 99.07
Forward PE 102.28
Dividend n/a
Ex-Dividend Date n/a
Volume 1,724,700
Average Volume 617,699
Open 285.60
Previous Close 280.80
Day's Range 207.60 - 302.40
52-Week Range 97.50 - 302.40
Beta n/a
RSI 62.13
Earnings Date Mar 30, 2026

About HKG:2637

Fujian Haixi Pharmaceuticals Co., Ltd. manufactures and sells pharmaceutical drugs in China. The company offers drugs for oncology, ophthalmology, digestion, cardiovascular, endocrine, and nervous systems, and inflammation. It sells its products through retail pharmacies, online pharmacies, and internet medical platforms. The company was incorporated in 2012 and is based in Fuzhou, China. [Read more]

Sector Healthcare
Founded 2012
Employees 164
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2637
Full Company Profile

Financial Performance

In 2025, HKG:2637's revenue was 582.36 million, an increase of 24.79% compared to the previous year's 466.68 million. Earnings were 177.03 million, an increase of 30.09%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.